首页> 美国卫生研究院文献>ACS Omega >Drug-Loaded Supramolecular Gels Prepared in a MicrofluidicPlatform: Distinctive Rheology and Delivery through Controlled Far-from-EquilibriumMixing
【2h】

Drug-Loaded Supramolecular Gels Prepared in a MicrofluidicPlatform: Distinctive Rheology and Delivery through Controlled Far-from-EquilibriumMixing

机译:微流控制备的载药超分子凝胶平台:独特的流变性和通过受控的非平衡传递混合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

It is shown here that controlled mixing of a gelator, drug, solvent, and antisolvent in a microfluidic channel leads to faster setting gels and more robust materials with longer release profiles than the physical gels of the same composition obtained using random mixing in solution. The system is similar to a related gelator system we had studied previously, but we were unable to apply the same gelling procedure because of the instability of the colloid caused by the small structural modification (length of the alkyl chain in the bis-imidazolium head group). This situation holds true for the gels formed with varying compositions and under different conditions (gelator/drug ratio, solvent proportion, and flow rates), with the most significant differences being the improved gel rheology and slower drug release rates. Very importantly, the gels (based on a previously unexplored system) have a higher water content ratio (water/EtOH 4:1) than others in the family, making their medicinal application more attractive. The gels were characterized by a variety of microscopy techniques, X-ray diffractionand infrared spectroscopy, and rheology. Salts of the antiinflammatorydrugs ibuprofen and indomethacin were successfully incorporated intothe gels. The diffraction experiments indicate that these compositegels with relatively short alkyl chains in the gelator component contrastto previous systems, in that they exhibit structural order and thepresence of crystalline areas of the drug molecule implying partialphase separation (even though these drug crystallites are not discernibleby microscopy). Furthermore, the release study with the gel incorporatingibuprofenate showed promising results that indicate a possible drugdelivery vehicle application for this and related systems.
机译:此处显示,与在溶液中随机混合所获得的相同组成的物理凝胶相比,凝胶剂,药物,溶剂和抗溶剂在微流体通道中的受控混合可导致更快凝固的凝胶和具有更长释放曲线的更坚固的材料。该系统类似于我们先前研究的相关胶凝剂系统,但是由于胶体的不稳定性是由小的结构修饰(双咪唑头部基团中的烷基链的长度)引起的,因此我们无法应用相同的胶凝程序)。对于由不同组成和在不同条件(胶凝剂/药物比,溶剂比例和流速)下形成的凝胶,这种情况仍然适用,最显着的差异是改善的凝胶流变性和较慢的药物释放速率。非常重要的是,该凝胶(基于以前未开发的系统)比家族中的其他凝胶具有更高的含水率(水/乙醇4:1),从而使其在医学上更具吸引力。通过各种显微镜技术,X射线衍射对凝胶进行表征红外光谱和流变学。抗炎盐药物布洛芬和消炎痛已成功并入凝胶。衍射实验表明,这些复合材料凝胶剂组分中烷基链相对较短的凝胶对比到以前的系统,因为它们表现出结构顺序和药物分子结晶区域的存在暗示了部分相分离(即使无法分辨出这些药物微晶通过显微镜)。此外,结合凝胶的释放研究布洛芬酸盐显示有希望的结果,表明可能的药物以及该系统和相关系统的交付车辆应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号